Live feed
Filing
SC 13G
SC 13G0001193125-17-047931·Viridian Therapeutics, Inc.\DE
Schedule 13G ownership disclosure
MIRAGEN THERAPEUTICS, INC.
Security class unavailable · CUSIP: 60463E103
Event date: 2017-02-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 12.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-17-047931
- Form type
- SC 13G
- Filer
- Viridian Therapeutics, Inc.\DE
- CIK
- CIK 1590750
- Filed
- Feb 17, 2017
- Reporting period
- Feb 13, 2017
- Description
- Schedule 13G beneficial ownership